Philip E. Cryer (1940 â 2024) was an American endocrinologist and physician-scientist known for his research on catecholamine physiology, glucose counter-regulation, and hypoglycemia-associated autonomic failure (HAAF), also known as Cryer Syndrome, in diabetes. He spent his career at Washington University School of Medicine where he directed both the Division of Endocrinology, Metabolism & Lipid Research and the General Clinical Research Center.
Philip Cryer was born on January 5, 1940 and grew up in El Paso, Illinois. His father was a physician. He completed his undergraduate education at Northwestern University (Phi Beta Kappa in 1962, and completed his medical degree at Northwestern's medical school (with Alpha Omega honors) in 1965. He completed residency and endocrinology fellowship training at Washington University School of Medicine and joined its faculty in 1971.
At Washington University, Cryer developed a highly sensitive single-isotope derivative method for measuring catecholamines (epinephrine and norepinephrine) in human plasma, improving the study of the human sympathoadrenal system. Using this assay, he and cardiology collaborators at Washington University examined catecholamine release during acute myocardial infarction, showing that elevated plasma catecholamines correlated with infarct size and mortality.
Cryer later shifted focus to the physiology of glucose counter-regulationâÂÂhow hormonal responses restore blood glucose during hypoglycemiaâÂÂand discovered that repeated hypoglycemia blunts this defense. He coined the term hypoglycemia-associated autonomic failure (HAAF) to describe this condition.
Cryer served as Director of the General Clinical Research Center (1973âÂÂ2006) and the Division of Endocrinology, Diabetes & Metabolism (1985âÂÂ2002) at Washington University. He was President of the American Diabetes Association (1992âÂÂ1993).
Cryer died on February 24, 2024 at age 84 in St. Louis, Missouri.
Cryer was married to Carolyn Elizabeth Havlin-Cryer until her death. She died on April 23, 2023, at the age of 80, in Saint Louis, Missouri.